Average Co-Inventor Count = 5.74
ph-index = 14
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Incyte Corporation (40 from 666 patents)
2. Incyte Holdings Corporation (20 from 147 patents)
3. Prelude Therapeutics Incorporated (1 from 18 patents)
41 patents:
1. 12448389 - BRM targeting compounds and associated methods of use
2. 12415809 - Pyrrolotriazine compounds as tam inhibitors
3. 12247020 - Bipyrazole derivatives as JAK inhibitors
4. 12201636 - Heterocyclylamines as PI3K inhibitors
5. 12152033 - Use of pyrazolopyrimidine derivatives for the treatment of PI3K-δ related disorders
6. 12030889 - Imidazopyridazine and imidazopyridine compounds and uses thereof
7. 11905275 - Bipyrazole derivatives as JAK inhibitors
8. 11851442 - Tricyclic fused thiophene derivatives as JAK inhibitors
9. 11819505 - Heterocyclylamines as PI3K inhibitors
10. 11780840 - Tricyclic urea compounds as JAK2 V617F inhibitors
11. 11767323 - Tricyclic pyridone compounds as JAK2 V617F inhibitors
12. 11613536 - Heterocyclic compounds as immunomodulators
13. 11591318 - Bipyrazole derivatives as JAK inhibitors
14. 11459329 - Imidazopyridazine and imidazopyridine compounds and uses thereof
15. 11433071 - Heterocyclylamines as PI3K inhibitors